TFAB002s, novel CD20-targeting T cell-dependent bispecific Fab-FabCH3 antibodies, exhibit potent antitumor efficacy against malignant B-cell lymphoma

• Qinghong Li,

  Roles Methodology, Project administration, Software, Writing – original draft

  Affiliation No.1 Research Laboratory, Shanghai Institute of Biological Products Co., Ltd., Shanghai, China

  https://orcid.org/0009-0004-4327-7795

  ⨯
• Kunming Zhang,

  Roles Methodology, Supervision, Writing – review & editing

  Affiliation No.1 Research Laboratory, Shanghai Institute of Biological Products Co., Ltd., Shanghai, China

  ⨯
• Yao Yu,

  Roles Data curation, Investigation, Methodology, Supervision, Writing – review & editing

  Affiliation No.1 Research Laboratory, Shanghai Institute of Biological Products Co., Ltd., Shanghai, China

  ⨯
• Zeng Yu,

  Roles Resources, Supervision, Writing – review & editing

  Affiliation No.1 Research Laboratory, Shanghai Institute of Biological Products Co., Ltd., Shanghai, China

  ⨯
• Jingyi Xu,

  Roles Methodology, Supervision, Writing – review & editing

  Affiliation No.1 Research Laboratory, Shanghai Institute of Biological Products Co., Ltd., Shanghai, China

  ⨯
• Wenyan Shen,

  Roles Methodology, Supervision, Writing – review & editing

  Affiliation No.1 Research Laboratory, Shanghai Institute of Biological Products Co., Ltd., Shanghai, China

  ⨯
• Lin Zhang,

  Roles Formal analysis

  Affiliation No.1 Research Laboratory, Shanghai Institute of Biological Products Co., Ltd., Shanghai, China

  ⨯
• Aidong Qu,

  Roles Conceptualization, Visualization, Writing – review & editing

  Affiliation No.1 Research Laboratory, Shanghai Institute of Biological Products Co., Ltd., Shanghai, China

  ⨯
• Hongyuan Liang

  Roles Conceptualization, Investigation, Supervision, Writing – review & editing

  * E-mail: lianghongyuan@sinopharm.com

  Affiliation No.1 Research Laboratory, Shanghai Institute of Biological Products Co., Ltd., Shanghai, China

  https://orcid.org/0009-0008-2678-2094

  ⨯